FibroBiologics: Advancing Next-Gen Therapies for Chronic Disease | Market Potential & Innovation
Автор: RedChip Companies
Загружено: 2025-07-01
Просмотров: 29087
Описание:
FibroBiologics (Nasdaq: FBLG) is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 160+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
Fibrobiologics is a client of RedChip. Visit www.redchip.com/stocks/FBLG to learn more.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
